January 24, 2011
1 min read
Save

Alcohol prep pads, swabs recalled by FDA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The FDA and Triad Group are conducting a voluntary recall of all lots of the manufacturer’s alcohol prep pads, alcohol swabs and alcohol swabsticks due to concerns about potential contamination with Bacillus cereus.

Patients and health care professionals using these products should immediately discontinue using the Triad Group alcohol prep pads and dispose of the pads in the trash. When preparing to take an injection, patients should use an alternative alcohol prep pad that is not subject to this recall or use a sterile gauze pad in conjunction with isopropyl alcohol.

The recalled lots are available in boxes of 100 individually packaged packets. The affected lots list Triad Group or one of the following third-party manufacturers on the package: Boca/Utilet; Cardinal Health; Conzellin; CVD; Moore Medical; PSS Select; VersaPro or Walgreens. These products were distributed in the United States, Canada and Europe.

According to a Triad Group press release: “This recall has been initiated due to concerns from a customer about potential contamination of the products with an objectionable organism. We are, out of an abundance of caution, recalling these lots to ensure that we are not the source of these contamination issues.”

In an update to the alert, Genentech issued an alert about Triad Group alcohol prep pads that are co-packaged and distributed with Genentech medicines, including Boniva injection, Fuzeon, Nutropin A.Q. Pen, Pegasys and TNKase. Merck issued a press release about Triad Group alcohol prep pads that are co-packaged and distributed with Merck medicines in Europe, Asia Pacific and Latin America; Merck medicines distributed in the United States are not impacted by the recall.

For more information on this recall, visit the FDA website.

Twitter Follow EndocrineToday.com on Twitter.